Similarly, analyses of SEs in four patient derived-xenografted (PDX) breast tumour samples revealed that an ER+ PR+ breast cancer sample has the breast cancer SE associated with CD47 while the other three PDX breast tumour samples (triple negative: ER−, PR−, Her2−) do not (Fig. 1b). This evidence concerns the gene ESR1 and breast carcinoma.